Privium Fund Management B.V. - PROQR THRAPEUTICS N V ownership

Quarter-by-quarter ownership
Privium Fund Management B.V. ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$6,947,780
-19.8%
5,344,4460.0%2.07%
+13.2%
Q2 2023$8,658,003
-23.9%
5,344,4460.0%1.82%
-52.3%
Q1 2023$11,383,670
-36.8%
5,344,4460.0%3.82%
-44.0%
Q4 2022$18,010,783
+346.0%
5,344,4460.0%6.83%
+365.6%
Q3 2022$4,038,000
-2.8%
5,344,4460.0%1.47%
+6.5%
Q2 2022$4,156,000
-12.4%
5,344,446
+1.9%
1.38%
+31.3%
Q1 2022$4,747,000
-87.8%
5,244,446
+10.0%
1.05%
-86.4%
Q4 2021$38,935,0004,765,6597.72%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q4 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 2,401,570$14,602,0002.94%
DAFNA Capital Management LLC 1,237,400$7,523,0002.17%
RTW INVESTMENTS, LP 4,902,785$29,809,0000.84%
Kerrisdale Advisers, LLC 453,182$2,755,0000.31%
COWEN AND COMPANY, LLC 300,042$1,824,0000.30%
Artal Group S.A. 1,259,177$7,656,0000.21%
ADAGE CAPITAL PARTNERS GP, L.L.C. 4,550,062$27,664,0000.07%
ALTRINSIC GLOBAL ADVISORS LLC 221,360$1,346,0000.06%
FRANKLIN STREET ADVISORS INC /NC 60,000$365,0000.04%
JENNISON ASSOCIATES LLC 2,625,514$15,963,0000.01%
View complete list of PROQR THRAPEUTICS N V shareholders